Cells scoring low on the miRNA-seq component of DLV 3 were susceptible to the knockout of EXOSC2. The overexpression of EXOSC2 has been previously shown to promote breast cancer cell growth, migration, angiogenesis and tumour formation, whereas its knockdown reduces these effects69. Here, EXOSC2 is linked to breast cancer.